FDA Accepts Biologics License Application for Proposed Denosumab Biosimilar
Drug Topics
MARCH 8, 2023
The drug, manufactured by Sandoz, will treat conditions including osteoporosis in postmenopausal women
Wed.Mar 08, 2023
469 
Woman of the Week: Lucy Therapeutics’ Amy Ripka
PharmaVoice
MARCH 8, 2023
How a 32-million-year-old fossil inspired the CEO to unlock the mysteries of mitochondrial dysfunction.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
FDA Approves Expanded Indication for Adjuvant Abemaciclib in HR+/HER2- Early Breast Cancer
Drug Topics
MARCH 8, 2023
The expansion was based on 4-year data from the monarchE study.
Targeting the new ‘Golden Girls’
PharmaVoice
MARCH 8, 2023
With unprecedented buying power, women over 50 wield a lot of influence — but are still underserved by pharma. Urovant hopes to change that with its potential blockbuster drug.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
What’s holding back health IT interoperability in 2023? ONC has some thoughts
Fierce Healthcare
MARCH 8, 2023
What’s holding back health IT interoperability in 2023?
New cell therapy company will treat solid tumours
European Pharmaceutical Review
MARCH 8, 2023
The joining of Adaptimmune Therapeutics and TCR² Therapeutics will form a new cell therapy company focused on treating solid tumours. Adrian Rawcliffe, Adaptimmune’s Chief Executive Officer asserted that the combined companies will work to gain “approval for the first engineered T-cell receptor (TCR) T-cell therapy for a solid tumour – afami-cel for the treatment of synovial sarcoma.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Walgreens-controlled VillageMD acquires Starling Physicians
Drug Store News
MARCH 8, 2023
Starling has more than 30 locations in Connecticut, offering primary care and a range of specialties.
SimplePractice launches therapist mentorship matchmaking pilot in California
Fierce Healthcare
MARCH 8, 2023
SimplePractice launches therapist mentorship matchmaking pilot in California agliadkovskaya Wed, 03/08/2023 - 16:16
Winn-Dixie lowers prices on more than 150 spring essentials
Drug Store News
MARCH 8, 2023
Through the Down Down program, customers can save more than 15% on average at their neighborhood store, the grocer said.
Are Medicare Advantage plans in trouble? Plan size and star ratings could matter a lot, experts say
Fierce Healthcare
MARCH 8, 2023
Are Medicare Advantage plans in trouble?
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
An Inside Look at Pharma Revenue Management
PharmExec
MARCH 8, 2023
According to the 2023 State of Revenue Report, pharma companies are prioritizing digital transformation while struggling with inflation and supply chain disruptions.
Opinion: How cross-state licensure reform can ease America’s mental health crisis
STAT
MARCH 8, 2023
Teletherapy has made mental health care more accessible than ever before, making care possible for people who otherwise would never have been able to get it. But the antiquated system of licensure in the United States is creating a huge barrier to realizing the potential for telehealth. I’ve seen the benefits of teletherapy firsthand. As the founder and CEO of Alma, a mental health company that helps independent mental health providers run their private practice and accept insurance, we s
WeightWatchers buys Sequence to expand into remote prescribing of hot weight loss drugs
Fierce Healthcare
MARCH 8, 2023
WeightWatchers buys Sequence to expand into remote prescribing of hot weight loss drugs aburky Wed, 03/08/2023 - 15:23
FDA issues rare comment on approval of Covid and flu home test from company that went bankrupt
STAT
MARCH 8, 2023
Last week, the Food and Drug Administration issued an emergency authorization for the first at-home Covid-19 and flu combination test. The news came just days after the test’s maker, Lucira, filed for bankruptcy, blaming the FDA’s “protracted” approval process for its financial problems. Now the FDA has released a rare comment clarifying what happened during its authorization process.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
How long does hyoscyamine take to work?
The Checkup by Singlecare
MARCH 8, 2023
When starting any new medication, a couple of key questions tend to bubble up, notably “Is this going to help me?” and “How long will it take to work?” Consider hyoscyamine , an antispasmodic medication that is often used to treat gastrointestinal (GI) tract disorders. You may know this medication by its brand names, such as Levsin , Anaspaz , Hyosyne , Symax, and Ed-Spaz—in fact, you might have even taken it for a stomach or intestinal problem.
STAT+: Many doctors spend their days battling insurers. Why do some go to work for ‘the dark side’?
STAT
MARCH 8, 2023
Gastroenterologist Alin Botoman had been on hold for almost an hour. The drone of muzak taunted him on speaker phone. It was the second day in a row he’d spent trying to get insurance to cover a dual CT/PET scan he’d already performed for his patient with esophageal cancer. The day before, after the insurance company unexpectedly denied the request, he’d called to contest the decision and spent an hour on hold.
Elevance Health study links heart problems to long COVID
Fierce Healthcare
MARCH 8, 2023
Elevance Health study links heart problems to long COVID fdiamond Wed, 03/08/2023 - 09:23
HHS secretary signals support for new restriction on addiction treatment
STAT
MARCH 8, 2023
WASHINGTON — A federal proposal to impose new restrictions on a key addiction-treatment medication has caused an uproar in certain segments of the medical community. But health secretary Xavier Becerra seems to be on board. The new Drug Enforcement Administration proposal would require that patients receive an in-person examination before obtaining refills of buprenorphine , a key drug used to treat opioid use disorder.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Degree Deodorant, Ciara partner to launch Unlimited collection
Drug Store News
MARCH 8, 2023
The collection offers five gender-neutral fragrances in both dry sprays and antiperspirant sticks.
‘A different type of fatigue’: One woman’s Parkinson’s diagnosis is a test of flexibility and gratitude
STAT
MARCH 8, 2023
“Living With” explores the contours of life with chronic illness, from the prelude to diagnosis to new patterns of living, to wrestling with big questions about illness and health. In 2020, Sandra Coplin, now 66, moved her life from her native New York — at the time, an epicenter of Covid’s devastation — to North Haven, Conn., to be close to family.
Natural allopregnanolone made orally bioavailable
European Pharmaceutical Review
MARCH 8, 2023
PureTech Health has announced it will advance its oral allopregnanolone candidate LYT-300, for the potential treatment of anxiety and postpartum depression (PPD). A placebo-controlled, Phase IIa, proof-of-concept, social anxiety clinical trial is expected to begin in the first half of 2023. The results are anticipated by the end of 2023. An open-label, Phase IIa, proof-of-concept clinical trial in women with PPD is expected to initiate in the second half of 2023.
Catering to men’s needs in skin care
Drug Store News
MARCH 8, 2023
With a focus on fragrance and men’s skin care, Slate Brands, says the company’s goal is to bring innovative products to the market.
Oral PCSK9 inhibitor substantially reduces cholesterol, study finds
European Pharmaceutical Review
MARCH 8, 2023
MK-0616, a daily oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, reduced low-density lipoprotein (LDL) cholesterol levels by around 60 percent in people with high cholesterol and/or heart disease in a Phase II trial. Developed by Merck & Co. Inc., MK-0616 is one of the first oral PCSK9 inhibitors to be tested in clinical trials.
RangeMe expands premium offerings to UK-focused brands
Drug Store News
MARCH 8, 2023
The premium subscription will provide brands with opportunities for increased visibility and engagement among the more than 1,000 U.K. buyers on the platform from leading retailers.
US FDA approves Shorla’s oncology drug for T-cell leukaemia
Pharmaceutical Technology
MARCH 8, 2023
The US Food and Drug Administration (FDA) has granted approval for Shorla Oncology’s Nelarabine Injection, an oncology drug, to treat T-cell leukaemia, an aggressive blood and bone marrow cancer that progresses quickly. The oncology drug has been approved to treat T-cell Lymphoblastic Lymphoma (T-LBL) and T-cell Acute Lymphoblastic Leukemia (T-ALL).
Giant, customers raise $1.3M to combat hunger
Drug Store News
MARCH 8, 2023
Customers at Giant, Martin’s and Giant Heirloom Market stores were invited to round up their grocery purchases to the nearest dollar or convert their Choice points into donations to support their local public school districts’ food programs.
Danaher and University of Pennsylvania partner for cell therapies
Pharmaceutical Technology
MARCH 8, 2023
Global science and technology innovator Danaher has entered a strategic collaboration with the University of Pennsylvania for cellular immunotherapies to address manufacturing challenges impacting cell therapy uptake. The multi-year collaboration aims to develop new technologies which will help in improving clinical outcomes for patients. The new technologies will also overcome the manufacturing bottlenecks in delivering advanced engineered cell products.
Hershey’s, Reese’s go plant-based
Drug Store News
MARCH 8, 2023
Made with dairy alternatives, the new launches include Hershey’s Plant Based Extra Creamy with Almonds and Sea Salt bars and Reese’s Plant Based Peanut Butter Cups.
STAT+: Pharmalittle: FDA head wants to get rid of advisory panel votes; premature-birth drug is finally withdrawn
STAT
MARCH 8, 2023
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Our choice today is caramel apple, a sweet treat.
Ghost, Cinnabon roll out vegan, whey protein powders
Drug Store News
MARCH 8, 2023
The companies have partnered to launch two nutritional powders that incorporate the authentic taste of a cinnamon roll.
Greater digital biomarklers adoption in clinical studies as Koneksa and SSI Strategy collaborate
Outsourcing Pharma
MARCH 8, 2023
The two partners will pool capabilities to provide an expanded service to their clients, which will see Koneksa provide its digital biomarkers tools and SSI Strategy its expertise in drug development.
Select Hy-Vee pharmacy locations in Iowa pilot COVID-19 and flu test-to-treat service
Drug Store News
MARCH 8, 2023
With one test, patients can get tested for both COVID-19 and flu and receive a prescribed treatment from a pharmacist.
STAT+: Medicare chief on the new drug price negotiation program’s operations, hiring, and timelines
STAT
MARCH 8, 2023
WASHINGTON — Medicare officials are still hammering out the technical specifics of how the massive program will start to negotiate drug prices — let alone the substantive ones, Medicare chief Meena Seshamani said at a STAT event Tuesday. “There are operations that need to be stood up both on the [Medicare] side and on the manufacturer side,” she said, describing “monthly technical calls.
Let's personalize your content